Table 2. Prevalence of Cardiovascular Risk Factors Among Participants in a Cardiovascular Screening Pilot Phase in Lebanon, 2012–2013.
| Variable | Men (n = 1,422) | Women (n = 2,783) | Total (N = 4,205) | P Valuea |
|---|---|---|---|---|
|
n (%) | ||||
| Smoking history | ||||
| Never smoked | 680 (47.8) | 1,652 (59.4) | 2,332 (55.5) | <.001 |
| Ex-smokers | 74 (5.2) | 80 (2.9) | 154 (3.7) | <.001 |
| Smokers and those who quit within the last year | 668 (47.0) | 1,051 (37.8) | 1,719 (40.9) | <.001 |
| Random blood glucoseb | ||||
| Unimpaired | 1,248 (87.8) | 2,500 (89.8) | 3,748 (89.1) | .04 |
| Impaired | 174 (12.2) | 283 (10.2) | 457 (10.9) | |
| Systolic blood pressurec | ||||
| Unimpaired | 1,094 (76.9) | 2,412 (86.7) | 3,506 (83.4) | <.001 |
| Impaired | 328 (23.1) | 371 (13.3) | 699 (16.6) | |
| Body mass index, kg/m2 | ||||
| <25.0 | 419 (29.5) | 913 (32.8) | 1,332 (31.7) | .03 |
| 25.0–29.9 | 623 (43.8) | 1,092 (39.2) | 1,715 (40.8) | .004 |
| ≥30 | 380 (26.7) | 778 (28.0) | 1,158 (27.5) | .40 |
| Waist circumference | ||||
| Normal | 563 (39.6) | 487 (17.5) | 1,050 (25.0) | <.001 |
| Elevated | 433 (30.5) | 675 (24.3) | 1,108 (26.3) | <.001 |
| Substantially elevated | 426 (30.0) | 1,621 (58.2) | 2,047 (48.7) | <.001 |
Abbreviation: WC, waist circumference.
a
P values calculated using χ2 test for dichotomous variables and using z test for variables with more than 2 categories.
b
Participants with fasting blood glucose higher than 110 mg/dL, those with a blood glucose level higher than 125 mg/dL at least 2 hours after their last meal, and those with blood glucose level higher than 135 mg/dL within 2 hours of their last meal were classified as having impaired blood glucose metabolism.
c
Participants were categorized as having impaired systolic blood pressure if pressure was 135 mm Hg or more.